Eagle Pharmaceuticals, Inc.
EGRX · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $254,486 | $370,488 | $380,457 | $347,870 |
| - Cash | $15,354 | $21,897 | $55,321 | $15,384 |
| + Debt | $71,615 | $76,329 | $62,466 | $61,392 |
| Enterprise Value | $310,747 | $424,920 | $387,602 | $393,878 |
| Revenue | $64,646 | $66,305 | $60,699 | $65,901 |
| % Growth | -2.5% | 9.2% | -7.9% | – |
| Gross Profit | $47,788 | $49,005 | $40,833 | $42,250 |
| % Margin | 73.9% | 73.9% | 67.3% | 64.1% |
| EBITDA | $16,326 | $17,307 | $21,194 | $2,152 |
| % Margin | 25.3% | 26.1% | 34.9% | 3.3% |
| Net Income | $5,164 | $5,750 | $8,165 | -$3,513 |
| % Margin | 8% | 8.7% | 13.5% | -5.3% |
| EPS Diluted | 0.39 | 0.44 | 0.62 | -0.27 |
| % Growth | -11.4% | -29% | 329.6% | – |
| Operating Cash Flow | -$126 | -$33,512 | $37,557 | -$13,237 |
| Capital Expenditures | -$6 | -$58 | -$10 | $0 |
| Free Cash Flow | -$132 | -$33,570 | $37,547 | -$13,237 |